Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Prep: Cook: Serves:

Michael J Fox applauds Nike as it raises million for his Foundation by auctioning pairs of the Nike Mag trainers with iconic ‘power laces’

Nike has raised US$6.75 million for the Michael J Fox Foundation (MJFF) after auctioning 88 pairs of the self-lacing ‘Mag’ trainers – as worn by Fox in the classic 1989 film ‘Back to the Future II’.

Trainer aficionados worldwide were invited to take part in an online draw for the chance to win a pair. They made donations of $10 per entry to the Foundation, which promised that all proceeds “will go straight to speeding a cure for Parkinson’s disease”.

Thanks to an anonymous donor, donations in the last 12 hours of the draw were doubled and matched dollar for dollar. The winners of the limited-edition sneakers were announced on October 17. The 89th pair of Nike Mags will be auctioned to the highest bidder at the Foundation’s benefit gala on November 12 in New York City.

A similar event took place in 2011, when Nike held a 10-day eBay auction of 1,500 pairs of Nike Mag sneakers. In total, the company has now raised more than $16 million for the Foundation.

Michael J Fox said: “Thanks to Nike, we’ve raised a boatload of money for research and we’ve had tons of fun while doing it. We’re grateful to everyone who’s engaged in our work and we welcome those who have come to learn more about us through this amazing partnership.”

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Misdiagnosed with Parkinson’s: why access to specialist neurologists is essential

What happens when your Parkinson’s diagnosis is actually wrong

The man who walked 80km in one day for Parkinson’s

Clint Bauld walked for 24 hours in aid of Parkinson’s

My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale

European coalition set to roll out new and simple composite scale

35 new Parkinson’s drug trials launched in last year

Researchers launched 35 new clinical trials of Parkinson’s drug therapies in the last year, according to recent findings published in the ‘Journal of Parkinson’s Disease’. The 2023 Parkinson’s drug development pipeline report noted a slight decrease in active trials compared to the 2022 update (down from 147 to 139 overall). About one-third of trials were still in Phase 1, half were in Phase 2 – and just 20 (14%) were in Phase 3, raising concerns about ‘slow progress’. However, of the active trials logged on ClinicalTrials.gov at the time of the latest report, 35 were found to be newly registered. The report authors concluded: “The slow progress and lack of agents transitioning from Phase 2 to Phase 3 is concerning, but collective efforts by various stakeholders are being made to accelerate the clinical trial process, with the aim of bringing new therapies to the [Parkinson’s] community sooner.”

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Misdiagnosed with Parkinson’s: why access to specialist neurologists is essential

Interviews

The man who walked 80km in one day for Parkinson’s

Europe

My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale

35 new Parkinson’s drug trials launched in last year

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

{title}

Subscribe

Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Misdiagnosed with Parkinson’s: why access to specialist neurologists is essential

Interviews

The man who walked 80km in one day for Parkinson’s

Europe

My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale

35 new Parkinson’s drug trials launched in last year

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

{title}

Subscribe

Sign in